Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients

Recruiting Observational Study
Nasopharyngeal Cancer Prostate Cancer Other Cancer
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
21 – 99
Sex
Any
Study type
Observational
Participants needed
5,000 (estimated)
Sponsor
National Cancer Centre, Singapore · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Patients with cancers that are sensitive to radiotherapy treatment and/or patients who have experienced severe acute/ late side effects to radiotherapy will be recruited to the study. Blood and/or matched tumour-normal tissue pairs will be collected. Blood and/or tissue samples will be processed and studied for genetic and biochemical markers that have potential to be used for predicting sensitivi…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients with severe side effects from radiotherapy * Patients with a type of cancer that is associated with sensitivity to radiotherapy Exclusion Criteria: * Age of patient must be between 21 (inclusive) and 99 (exclusive)
Contacts

Melvin Chua, MD

melvin.chua.l.k@singhealth.com.sg

CONTACT

Enya Ong

+65 6436 8000

enya.ong.h.w@nccs.com.sg

CONTACT